Literature DB >> 8199193

Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness.

W Birchmeier1, J Behrens.   

Abstract

It has been realized that the loss of epithelial differentiation in carcinomas, which is accompanied by higher mobility and invasiveness of the tumor cells, is often a consequence of reduced intercellular adhesion. A variety of recent reports have indicated that the primary cause for the 'scattering' of the cells in invasive carcinomas is a disturbance of the integrity of intercellular junctions, often involving loss of a functional cell-cell adhesion molecule E-cadherin. It has also been suggested that during invasion, carcinoma cells convert to a sort of mesenchymal stage, as do normal epithelial cells during development. In the present review, permanent and transient molecular mechanisms are discussed which lead to the impairment of junction integrity of the epithelial cells and thus to the progression of carcinomas towards a more metastatic state. Furthermore, the now extensive literature on the down-regulation of E-cadherin expression in human and animal carcinomas is reviewed in detail.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8199193     DOI: 10.1016/0304-419x(94)90003-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  300 in total

1.  Changing roles of cadherins and catenins during progression of squamous intraepithelial lesions in the uterine cervix.

Authors:  C J de Boer; E van Dorst; H van Krieken; C M Jansen-van Rhijn; S O Warnaar; G J Fleuren; S V Litvinov
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

2.  Na,K-ATPase beta-subunit is required for epithelial polarization, suppression of invasion, and cell motility.

Authors:  S A Rajasekaran; L G Palmer; K Quan; J F Harper; W J Ball; N H Bander; A Peralta Soler; A K Rajasekaran
Journal:  Mol Biol Cell       Date:  2001-02       Impact factor: 4.138

3.  Epstein-Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates Akt.

Authors:  F Scholle; K M Bendt; N Raab-Traub
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

4.  Crystal structure of the M-fragment of alpha-catenin: implications for modulation of cell adhesion.

Authors:  J Yang; P Dokurno; N K Tonks; D Barford
Journal:  EMBO J       Date:  2001-07-16       Impact factor: 11.598

5.  Fast dissociation kinetics between individual E-cadherin fragments revealed by flow chamber analysis.

Authors:  Emilie Perret; Anne-Marie Benoliel; Pierre Nassoy; Anne Pierres; Véronique Delmas; Jean-Paul Thiery; Pierre Bongrand; Hélène Feracci
Journal:  EMBO J       Date:  2002-06-03       Impact factor: 11.598

Review 6.  Involvement of members of the cadherin superfamily in cancer.

Authors:  Geert Berx; Frans van Roy
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-09-23       Impact factor: 10.005

7.  Polycomb group protein EZH2-mediated E-cadherin repression promotes metastasis of oral tongue squamous cell carcinoma.

Authors:  Cheng Wang; Xiqiang Liu; Zujian Chen; Hongzhang Huang; Yi Jin; Antonia Kolokythas; Anxun Wang; Yang Dai; David T W Wong; Xiaofeng Zhou
Journal:  Mol Carcinog       Date:  2011-12-07       Impact factor: 4.784

Review 8.  Epithelial cell polarity, stem cells and cancer.

Authors:  Fernando Martin-Belmonte; Mirna Perez-Moreno
Journal:  Nat Rev Cancer       Date:  2011-12-15       Impact factor: 60.716

9.  Expression of cholecystokinin-2/gastrin receptor in the murine pancreas modulates cell adhesion and cell differentiation in vivo.

Authors:  Christiane Bierkamp; Stéphanie Bonhoure; Anne Mathieu; Pascal Clerc; Daniel Fourmy; Lucien Pradayrol; Catherine Seva; Marlène Dufresne
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

10.  Relationship of sialyl-Lewis(x/a) underexpression and E-cadherin overexpression in the lymphovascular embolus of inflammatory breast carcinoma.

Authors:  Mary L Alpaugh; James S Tomlinson; Yin Ye; Sanford H Barsky
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.